Partnership to focus on advanced molecular diagnostic solutions for key health challenges including diabetic foot infection – reducing risk of serious complications Mylab Discovery Solutions, India’s leading biotech company, and DnaNudge, a UK-based pioneer of consumer genetics testing and medical diagnostics, today announced a
Designed to deliver confidence and reliability for diagnostic development and testing, the Applied Biosystems™ TaqPath™ PCR kits for infectious diseases such as Multi-Drug Resistant Tuberculosis (MTB MDR), M. Tuberculosis complex (MTB), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and for
It is a highly accurate test and detects all COVID-19 variants in 20 seconds It will be available in international markets later this year Mylab Discovery Solutions, India’s leading biotechnology company, and Portland, OR-based Hemex Health, a medical diagnostic device company focused on creating diagnostics
